Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

2024/05/07 by Antonio González-Martı́n, Antonio González-Martín, Hyun Cheol Chung +17
Medicine · #Cancer Immunotherapy and Biomarkers #Ovarian cancer diagnosis and treatment #PARP inhibition in cancer therapy

paper · pdf · doi:10.1016/j.ygyno.2024.04.011

openalex publication_date 2024/05/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Epithelial ovarian cancer: Evolution of management in the era of precision medicine